Arcturus Therapeutics Holdings (ARCT) Retained Earnings (2018 - 2025)
Historic Retained Earnings for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$485.5 million.
- Arcturus Therapeutics Holdings' Retained Earnings fell 1592.85% to -$485.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$485.5 million, marking a year-over-year decrease of 1592.85%. This contributed to the annual value of -$448.8 million for FY2024, which is 2199.16% down from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Retained Earnings stood at -$485.5 million for Q3 2025, which was down 1592.85% from -$472.1 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Retained Earnings registered a high of -$200.2 million during Q1 2021, and its lowest value of -$485.5 million during Q3 2025.
- For the 5-year period, Arcturus Therapeutics Holdings' Retained Earnings averaged around -$377.4 million, with its median value being -$394.7 million (2024).
- Its Retained Earnings has fluctuated over the past 5 years, first tumbled by 17777.62% in 2021, then skyrocketed by 2791.57% in 2023.
- Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' Retained Earnings stood at -$347.5 million in 2021, then increased by 2.69% to -$338.1 million in 2022, then dropped by 8.8% to -$367.9 million in 2023, then fell by 21.99% to -$448.8 million in 2024, then fell by 8.18% to -$485.5 million in 2025.
- Its Retained Earnings was -$485.5 million in Q3 2025, compared to -$472.1 million in Q2 2025 and -$462.9 million in Q1 2025.